CSPC Pharmaceutical Group Limited
CSPCY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $53,798 | $85,516 | $94,923 | $100,177 |
| - Cash | $6,777 | $12,015 | $11,655 | $9,284 |
| + Debt | $507 | $707 | $621 | $103 |
| Enterprise Value | $47,528 | $74,208 | $83,890 | $90,996 |
| Revenue | $30,868 | $34,599 | $35,012 | $34,188 |
| % Growth | -10.8% | -1.2% | 2.4% | – |
| Gross Profit | $21,599 | $24,397 | $22,726 | $25,472 |
| % Margin | 70% | 70.5% | 64.9% | 74.5% |
| EBITDA | $6,865 | $8,533 | $8,655 | $9,275 |
| % Margin | 22.2% | 24.7% | 24.7% | 27.1% |
| Net Income | $4,605 | $5,873 | $6,894 | $6,877 |
| % Margin | 14.9% | 17% | 19.7% | 20.1% |
| EPS Diluted | 1.56 | 2 | 2.04 | 1.88 |
| % Growth | -22% | -2% | 8.5% | – |
| Operating Cash Flow | $4,535 | $4,179 | $7,627 | $4,637 |
| Capital Expenditures | -$2,679 | -$1,893 | -$2,723 | -$1,758 |
| Free Cash Flow | $1,856 | $2,286 | $4,904 | $2,878 |